Biopsies and Pathology Reports
At a Glance
A definitive diagnosis of Primary Cutaneous Amyloidosis (PCA) requires a skin biopsy. Pathologists use a Congo Red stain, which glows apple-green under polarized light, to confirm amyloid deposits. A CK5/6 test is then used to prove the amyloid originated from damaged skin cells.
Understanding your pathology report is a key step in managing Primary Cutaneous Amyloidosis (PCA). While a doctor may suspect PCA by looking at your skin, a definitive diagnosis almost always requires a skin biopsy and specialized laboratory tests to confirm the presence of amyloid proteins [1][2]. To understand the specific subtype diagnosed in your report, review The Subtypes: Macular, Lichen, Nodular, and Biphasic.
Initial Clues: Dermoscopy
Before a biopsy, your dermatologist may use a dermoscope—a specialized magnifying tool—to look at the surface of your skin [3]. In PCA, this often reveals a central hub pattern [3][4]. This appears as a white or brown “hub” surrounded by a halo of pigment, which correlates with the amyloid deposits and melanin (pigment) hiding just beneath the skin’s surface [4][5].
The Definitive Test: Skin Biopsy
To confirm the diagnosis, a small piece of skin is removed (a biopsy) and sent to a pathologist. They use specific tools to identify the amyloid:
- Congo Red Stain: This is the “gold standard” test [2]. When this red dye is applied to the tissue and viewed under specialized polarized light, the amyloid deposits glow with a distinct apple-green birefringence [2][6].
- CK5/6 Immunohistochemistry (IHC): This test uses antibodies to identify the origin of the amyloid [2]. In macular and lichen subtypes, the amyloid comes from damaged skin cells (keratinocytes) [2]. A positive CK5/6 result proves the amyloid is keratinocyte-derived.
Decoding Your Pathology Report
Pathology reports often contain technical terms:
- Papillary Dermis: The top layer of the dermis where amyloid deposits in PCA are typically found [1][2].
- Eosinophilic Deposits: Clusters that appear pink when stained with standard laboratory dyes [3].
- Amorphous: The deposits have no specific shape or structure [3].
- Melanin Incontinence: Pigment has “leaked” out of the top layer of skin and into the deeper layers, contributing to the dark patches [4].
Completeness Checklist
A comprehensive pathology report for PCA should ideally include:
- Congo Red Results: Explicit mention of whether the stain was positive and if apple-green birefringence was observed [2].
- Location of Deposits: Confirmation that deposits are in the papillary dermis (typical for macular/lichen) or deeper (typical for nodular) [1][7].
- Special Stains (IHC): Use of markers like CK5/6 to confirm the keratin origin [2].
- Subtype Classification: A concluding diagnosis specifying if it is Macular, Lichen, Biphasic, or Nodular amyloidosis [8].
- Light Chain Analysis: For nodular type, checks for Kappa or Lambda light chains to help rule out systemic involvement [7][9].
Common questions in this guide
What does a Congo Red stain show for cutaneous amyloidosis?
Why is a CK5/6 test used on my skin biopsy?
What does 'papillary dermis' mean on my pathology report?
Why does my biopsy report mention melanin incontinence?
What does light chain testing mean for nodular amyloidosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my report confirm the presence of 'apple-green birefringence' under polarized light?
- 2.Was CK5/6 staining performed to verify the amyloid is from skin cells (keratinocytes)?
- 3.Does the report indicate if the amyloid is in the papillary dermis or deeper in the skin?
- 4.If I have nodular amyloidosis, does the report show 'light chain restriction' (Kappa or Lambda)?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Tofacitinib for the treatment of primary cutaneous amyloidosis: A case report.
Chen J, Yang B
Dermatologic therapy 2022; (35(4)):e15312 doi:10.1111/dth.15312.
PMID: 35001465 - 2
Primary cutaneous amyloidosis: A clinicopathological, histochemical, and immunohistochemical study.
Sinha A, Manjunath GV, Basavaraj V
Indian journal of pathology & microbiology 2021; (64(2)):323-328 doi:10.4103/IJPM.IJPM_32_20.
PMID: 33851627 - 3
Diagnosing of primary cutaneous amyloidosis using dermoscopy and reflectance confocal microscopy.
Lei W, Ai-E X
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 2022; (28(3)):433-438 doi:10.1111/srt.13143.
PMID: 35188697 - 4
FotoFinder Dermoscopy Analysis and Histopathological Correlation in Primary Localized Cutaneous Amyloidosis.
Madarkar MS, Koti VR
Dermatology practical & conceptual 2021; (11(3)):e2021057 doi:10.5826/dpc.1103a57.
PMID: 34123561 - 5
Dermoscopy aids in differentiating primary cutaneous amyloidosis and post-inflammatory hyperpigmentation: A clinico-dermoscopic-histopathaological study.
El-Samanoudy SI, Gawdat HI, Fouda KM, Abdelkader HA
Journal of cosmetic dermatology 2022; (21(11)):6434-6440 doi:10.1111/jocd.15332.
PMID: 36017750 - 6
Histopathological Insights into Primary Localized Cutaneous Amyloidosis: A Case Series.
Einstien D, G S, Vishali V M S, et al.
Cureus 2025; (17(2)):e79603 doi:10.7759/cureus.79603.
PMID: 40151750 - 7
Nodular Cutaneous Amyloidosis on the Nose Confirmed Using Electron Microscopy: A Case Report.
Choi GW, Kim DH
Annals of dermatology 2023; (35(Suppl 2)):S376-S377 doi:10.5021/ad.22.075.
PMID: 38061751 - 8
Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib.
Xia D, Xiao Y, Li M, Li W
Dermatologic therapy 2022; (35(9)):e15724 doi:10.1111/dth.15724.
PMID: 35855568 - 9
A suspicious nodule in a toe web space.
Gilbert G, Wiggins J, Biswas A, Gupta G
Clinical and experimental dermatology 2025; (50(8)):1704-1706 doi:10.1093/ced/llaf113.
PMID: 40059631
This page explains primary cutaneous amyloidosis pathology terminology for educational purposes. Your dermatologist and pathologist are the best sources for interpreting your specific biopsy report.
Get notified when new evidence is published on Primary cutaneous amyloidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.